Literature DB >> 11953397

Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivo.

J Reid Schwebach1, Aharona Glatman-Freedman, Leslie Gunther-Cummins, Zhongdong Dai, John B Robbins, Rachel Schneerson, Arturo Casadevall.   

Abstract

The outermost layer of Mycobacterium tuberculosis is composed primarily of two polysaccharides, glucan (GC) and arabinomannan. To analyze the surface polysaccharide composition of M. tuberculosis, we generated a monoclonal antibody (MAb) that binds M. tuberculosis GC and is known as MAb 24c5. Immunofluorescence and whole-mount immunoelectron microscopy indicated that GC is on the outermost portion of the bacteria. M. tuberculosis strains Erdman and CDC 1551 were analyzed for their ability to bind MAb 24c5 after in vitro growth in media with and without the detergent Tween 80. MAb 24c5 bound to Erdman and CDC 1551 at all culture times with only slightly greater apparent affinity after extended culture in the absence of Tween 80, indicating that a stable amount of GC polysaccharide antigen is associated with the cell surface of M. tuberculosis. An enzyme-linked immunosorbent assay indicated that GC is antigenically similar to glycogen, and the amount of GC antigen increased in the media of M. tuberculosis cultures grown either with or without the detergent Tween 80. Other nontuberculosis mycobacteria have antigenically similar GCs on their surfaces after in vitro growth. Inoculation of mice with live bacilli but not inoculation with dead bacilli elicited a strong antibody response to GC consistent with production of this antigen in vivo. Our results provide a more comprehensive picture of the M. tuberculosis cell envelope and the conditions that allow expression of M. tuberculosis GC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953397      PMCID: PMC127896          DOI: 10.1128/IAI.70.5.2566-2575.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.

Authors:  E Konadu; J Shiloach; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  The isolation of three different proteins and two polysaccharides from tuberculin by alcohol fractionation; their chemical and biological properties.

Authors:  F B SEIBERT
Journal:  Am Rev Tuberc       Date:  1949-01

3.  Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria.

Authors:  A Glatman-Freedman; J M Martin; P F Riska; B R Bloom; A Casadevall
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

Review 4.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

5.  Influence of the age of mycobacterial cultures on the protein and carbohydrate composition of tuberculins.

Authors:  R Turcotte; Y Des Ormeaux
Journal:  Can J Microbiol       Date:  1972-05       Impact factor: 2.419

6.  Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis.

Authors:  A Lemassu; M Daffé
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

7.  Molecular composition of the outermost capsular material of the tubercle bacillus.

Authors:  A Ortalo-Magné; M A Dupont; A Lemassu; A B Andersen; P Gounon; M Daffé
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

8.  Monoclonal antibody based ELISAs for cryptococcal polysaccharide.

Authors:  A Casadevall; J Mukherjee; M D Scharff
Journal:  J Immunol Methods       Date:  1992-09-18       Impact factor: 2.303

Review 9.  The envelope of mycobacteria.

Authors:  P J Brennan; H Nikaido
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

10.  Novel method for rapid measurement of growth of mycobacteria in detergent-free media.

Authors:  P R Meyers; W R Bourn; L M Steyn; P D van Helden; A D Beyers; G D Brown
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more
  17 in total

1.  Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status.

Authors:  Xian Yu; Rafael Prados-Rosales; Elisabeth R Jenny-Avital; Katherine Sosa; Arturo Casadevall; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

Review 2.  Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.

Authors:  Jacqueline M Achkar; Rafael Prados-Rosales
Journal:  Curr Opin Immunol       Date:  2018-04-12       Impact factor: 7.486

3.  Capsular glucan and intracellular glycogen of Mycobacterium tuberculosis: biosynthesis and impact on the persistence in mice.

Authors:  Tounkang Sambou; Premkumar Dinadayala; Gustavo Stadthagen; Nathalie Barilone; Yann Bordat; Patricia Constant; Florence Levillain; Olivier Neyrolles; Brigitte Gicquel; Anne Lemassu; Mamadou Daffé; Mary Jackson
Journal:  Mol Microbiol       Date:  2008-09-18       Impact factor: 3.501

4.  Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice.

Authors:  Rafael Prados-Rosales; Andres Baena; Luis R Martinez; Jose Luque-Garcia; Rainer Kalscheuer; Usha Veeraraghavan; Carmen Camara; Joshua D Nosanchuk; Gurdyal S Besra; Bing Chen; Juan Jimenez; Aharona Glatman-Freedman; William R Jacobs; Steven A Porcelli; Arturo Casadevall
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

5.  The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.

Authors:  Rafael Prados-Rosales; Leandro J Carreño; Brian Weinrick; Ana Batista-Gonzalez; Aarona Glatman-Freedman; Jiayong Xu; John Chan; William R Jacobs; Steven A Porcelli; Arturo Casadevall
Journal:  J Infect Dis       Date:  2016-04-18       Impact factor: 5.226

Review 6.  The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis.

Authors:  Rainer Kalscheuer; Ainhoa Palacios; Itxaso Anso; Javier Cifuente; Juan Anguita; William R Jacobs; Marcelo E Guerin; Rafael Prados-Rosales
Journal:  Biochem J       Date:  2019-07-18       Impact factor: 3.857

7.  The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages.

Authors:  Richard W Stokes; Raymond Norris-Jones; Donald E Brooks; Terry J Beveridge; Dan Doxsee; Lisa M Thorson
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins.

Authors:  Musa Sani; Edith N G Houben; Jeroen Geurtsen; Jason Pierson; Karin de Punder; Maaike van Zon; Brigitte Wever; Sander R Piersma; Connie R Jiménez; Mamadou Daffé; Ben J Appelmelk; Wilbert Bitter; Nicole van der Wel; Peter J Peters
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

9.  Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51.

Authors:  Ban Al-Sayyed; Sajida Piperdi; Xinni Yuan; Anping Li; Gurdyal S Besra; William R Jacobs; Arturo Casadevall; Aharona Glatman-Freedman
Journal:  Tuberculosis (Edinb)       Date:  2007-09-19       Impact factor: 3.131

10.  Mycobacterium tuberculosis Cpn60.2 and DnaK are located on the bacterial surface, where Cpn60.2 facilitates efficient bacterial association with macrophages.

Authors:  Tyler B M Hickey; Lisa M Thorson; David P Speert; Mamadou Daffé; Richard W Stokes
Journal:  Infect Immun       Date:  2009-05-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.